Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

2.16
Delayed Data
As of May 27
 -0.11 / -4.85%
Today’s Change
0.61
Today|||52-Week Range
3.50
+157.08%
Year-to-Date

Today’s Trading

Previous close2.27
Today’s open2.22
Day’s range-- - --
Volume3,674,391
Average volume (3 months)3,453,578
Market cap$125.0M
Dividend yield--
Data as of 05/27/2015

Growth & Valuation

Earnings growth (last year)+51.90%
Earnings growth (this year)+20.46%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,301.62%
P/E ratioNM
Price/Sales2.42
Price/Book5.76

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...-0.04-0.80%
EPRSEPIRUS Biopharmaceut...+0.58+10.72%
RNNRexahn Pharmaceutica...+0.01+2.00%
SCYXSCYNEXIS Inc-0.12-1.37%
Data as of 4:14pm ET, 05/27/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$18.1M
Annual profit (last year)-$52.7M
Net profit margin-291.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Keith S. Ehrlich
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers